The National Institute for Health and Care Excellence (NICE) has recommended the use of four out of six disease-modifying therapies in relapsing–remitting multiple sclerosis.
Browsing: Movement disorders
An abstract to be presented by the American Academy of Neurology (CA, USA) reports patients suffering from hand tremors may find relief with a novel, non-invasive nerve stimulation treatment.
A recently published study has indicated that all degrees of concussion may increase the risk of developing Parkinson’s disease.
This research article from Neurodegenerative Disease Management investigates how age and disease duration affects Parkinson’s treatment outcome with levodopa-carbidopa intestinal gel.
We bring together Parkinson’s advances from across research and industry from the year so far.
In this week’s round-up, we cover the latest industry news from depression and Parkinson’s disease. Find out more about our selection of the highlights this week.
Researchers have uncovered the role of calcium and how it interacts with alpha-synuclein in the development of Parkinson’s disease.
A new study from TauRx reports success in reversing symptoms of Parkinson’s disease in mouse models treated with LTMX.
Russell Kern reports on the 6-month update on the first-in-human clinical study of neural stem cells in patients with Parkinson’s disease.